Emerging Trends in Lipoprotein and Cardiovascular Diseases

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Endocrinology and Metabolism Research".

Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 5845

Special Issue Editors


E-Mail Website
Guest Editor
Department of Family Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
Interests: health promotion for cardiometabolic diseases

E-Mail Website
Guest Editor
Department of Family Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
Interests: medicine; cardiovascular diseases; HDL

Special Issue Information

Dear Colleagues,

High-density lipoproteins (HDL) have a unique lipid metabolism status, and have important clinical implications as biomarkers. It is well known that low HDL cholesterol is a risk factor for atherosclerotic cardiovascular disease; however, many clinical concerns require further investigation. HDL cholesterol interacts, directly or indirectly, with various substances in the blood, as well as with other lipids. Furthermore, HDL cholesterol has several subclasses, and additional research is required to better understand how they work differently to cardiometabolic health issues. Furthermore, detailing implications according to gender, ethnicity, age group, and interrelationships with drugs and nutrition will also be critical biomedical aspects to consider in clinical settings. Beyond the conventional understanding of HDL cholesterol, it is time for advanced research pertaining to technological advances in various clinical contexts. We encourage worldwide participation from researchers interested in cardiovascular and metabolic health.

Prof. Dr. Yong-Jae Lee
Dr. Byoungjin Park
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • high-density lipoproteins
  • cardiovascular disease
  • molecular interactions in cardiometabolic health
  • cardiovascular risk prediction

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

13 pages, 1361 KiB  
Article
Small Dense LDL Level and LDL/HDL Distribution in Acute Coronary Syndrome Patients
by Alyann Otrante, Abdelghani Bounafaa, Hicham Berrougui, Abdel-Khalid Essamadi, Michel Nguyen, Tamàs Fülöp and Abdelouahed Khalil
Biomedicines 2023, 11(4), 1198; https://doi.org/10.3390/biomedicines11041198 - 18 Apr 2023
Cited by 2 | Viewed by 1860
Abstract
This study aimed to determine the size and distribution of LDL and HDL particles in North African acute coronary syndrome (ACS) patients and to compare the level of small dense LDL (sdLDL) to other markers used in cardiovascular risk prediction. Methods: A total [...] Read more.
This study aimed to determine the size and distribution of LDL and HDL particles in North African acute coronary syndrome (ACS) patients and to compare the level of small dense LDL (sdLDL) to other markers used in cardiovascular risk prediction. Methods: A total of 205 ACS patients and 100 healthy control subjects were enrolled. LDL particle size and LDL and HDL subclass distributions were measured using Quantimetric Lipoprint® linear polyacrylamide gel electrophoresis. Lipid ratios (total cholesterol, LDL cholesterol, non-HDL cholesterol, and HDL cholesterol) were determined to calculate the atherogenic index of plasma (AIP), the atherogenic coefficient (AC), Castelli’s Risk-I (CR-I), and Castelli’s Risk-II (CR-II). Receiver operating characteristic (ROC) curve analyses and area under the curve (AUC) were used to assess the predictive value of sdLDL as a marker for cardiovascular disease. Results: The ACS patients, compared to the healthy control subjects, displayed an alteration of LDL particle distribution, with a significant increase in sdLDL serum concentrations (0.303 ± 0.478 mmol/L vs. 0.0225 ± 0.043 mmol/L, respectively, p < 0.001). The sdLDL levels had a high discrimination accuracy [AUC = 0.847 ± 0.0353 (95% CI 0.778 to 0.916, p < 0.0001)]. The best predictive cutoff value of ACS determined with the maximum Youden index (J) [(sensitivity + specificity) − 1 = 0.60] was 0.038 mmol/L. A Spearman correlation analysis showed that sdLDL levels were moderately but significantly and positively correlated with AC and CR-I (r = 0.37, p < 0.001) and weakly but significantly correlated with PAI and CR-II; r = 0.32 (p < 0.001) and r = 0.30 (p < 0.008), respectively. The subclass distribution of HDL particles from ACS patients was also altered, with a decrease in large HDL particles and an increase in small HDL particles compared to HDL from healthy control subjects. Conclusion: Due to their high atherogenicity, sdLDL levels could be used as a valuable marker for the prediction cardiovascular events. Full article
(This article belongs to the Special Issue Emerging Trends in Lipoprotein and Cardiovascular Diseases)
Show Figures

Figure 1

8 pages, 613 KiB  
Article
Predictive Value of Serum Uric Acid to HDL Cholesterol Ratio for Incident Ischemic Heart Disease in Non-Diabetic Koreans
by Byoungjin Park, Dong-Hyuk Jung and Yong-Jae Lee
Biomedicines 2022, 10(6), 1422; https://doi.org/10.3390/biomedicines10061422 - 15 Jun 2022
Cited by 16 | Viewed by 1920
Abstract
HDL cholesterol, besides its function in lipid metabolism, plays a role in suppressing blood oxidation reactions and protecting vascular endothelial cells. The uric acid/HDL cholesterol ratio (UHR) has recently attracted attention as a new biomarker for evaluating interactions between inflammatory and anti-inflammatory substances [...] Read more.
HDL cholesterol, besides its function in lipid metabolism, plays a role in suppressing blood oxidation reactions and protecting vascular endothelial cells. The uric acid/HDL cholesterol ratio (UHR) has recently attracted attention as a new biomarker for evaluating interactions between inflammatory and anti-inflammatory substances in the blood. This study aimed to investigate the longitudinal association between UHR and incident ischemic heart disease (IHD). Data from 16,455 participants without diabetes from the Health Risk Assessment Study (HERAS) and Korean Health Insurance Review and Assessment (HIRA) were assessed. Over 50 months after baseline enrolment, 321 (2.0%) participants developed IHD. The HRs of incident IHD were 0.85 (95% CI, 0.55–1.29), 1.42 (95% CI, 0.94–2.13), and 1.57 (95% CI, 1.01–2.45) in the second, third, and fourth UHR quartiles, respectively, after adjusting for potential confounding variables. In the subgroup analysis by sex-specific quartile, women tended to have higher HRs in the highest UHR quartile. We found that high UHR values were positively associated with incident IHD in Koreans without diabetes. An increased UHR may be a useful measure by which to assess cardiovascular risk in the preclinical stage. Full article
(This article belongs to the Special Issue Emerging Trends in Lipoprotein and Cardiovascular Diseases)
Show Figures

Figure 1

Review

Jump to: Research

12 pages, 561 KiB  
Review
Familial Hypercholesterolaemia as a Predisposing Factor for Atherosclerosis
by Anastasia V. Poznyak, Larisa Litvinova, Paolo Poggio, Alexander N. Orekhov and Alexandra A. Melnichenko
Biomedicines 2022, 10(10), 2639; https://doi.org/10.3390/biomedicines10102639 - 20 Oct 2022
Cited by 2 | Viewed by 1468
Abstract
Lipid metabolism alterations are an important component of the pathogenesis of atherosclerosis. However, it is now clear that the atherogenesis process involves more than one mechanism, and more than one condition can predispose this condition. Multiple risk factors contribute to the atherosclerosis initiation [...] Read more.
Lipid metabolism alterations are an important component of the pathogenesis of atherosclerosis. However, it is now clear that the atherogenesis process involves more than one mechanism, and more than one condition can predispose this condition. Multiple risk factors contribute to the atherosclerosis initiation and define its course. Familial hypercholesterolaemia is a disorder of lipid metabolism that often leads to atherosclerosis development. As is clear from the disease name, the hallmark is the increased levels of low-density lipoprotein cholesterol (LDL-C) in blood. This creates favourable conditions for atherogenesis. In this review, we briefly described the familial hypercholesterolaemia and summarized data on the relationship between familial hypercholesterolaemia and atherosclerosis. Full article
(This article belongs to the Special Issue Emerging Trends in Lipoprotein and Cardiovascular Diseases)
Show Figures

Figure 1

Back to TopTop